# Keith O'Neill

CEO of Vivid Dx (Oxford Science Park, Oxford University spin-out), appointed in January, 25 years of experience in medical innovation; the company uses AI + Raman spectroscopy to identify infectious pathogens within minutes, and has won USD 15 million seed from Oxford Science Enterprises and others (Source: vivid-dx.com official website leadership, PR Newswire 2026-07) (2026, 30, 7).

CEO of Vivid Dx (Oxford Science Park, Oxford University spin-out), appointed in January, 25 years of experience in medical innovation; the company uses AI + Raman spectroscopy to identify infectious pathogens within minutes, and has won USD 15 million seed from Oxford Science Enterprises and others (Source: vivid-dx.com official website leadership, PR Newswire 2026-07) (2026, 30, 7).

Canonical: https://uniquebase.ai/people/keith-o-neill
Stable identifier: UB-P3634
Snapshot captured: 2026-10-22T00:48:04.883Z
English updated: 2026-10-22T03:03:53.557Z

## Connected profiles

- [Vivid Dx](/companies/vivid-dx)

## Sources

- No source links are available for this profile.